주메뉴 바로가기
서브메뉴 바로가기
본문 바로가기
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15
R&D
Laboratory
Pipeline
Technology
IR
IR Resource
Public Disclosures
Public Disclosures
PR
Notice
News
Materials
Careers
Talents
Welfare
Recruitment
KOR
ENG
Goldmmune
TEL
menu open
VaxcellBio, Inc.
KOR
ENG
menu close
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15 for Companion Animals
R&D
Laboratory
Pipeline
Technology
IR
Public Disclosures
Careers
Talents
Welfare
Recruitment
ⓒ VaxCell Biotherapeutics Co., Ltd.
PR
Notice
News
Materials
News
•
홈
> PR >
News
뉴스(한국경제) - 박셀바이오 "신약 후보물질 'Vax-NK' 조건부 허가 상반기 판가름 날 것"
관리자
2024. 01. 16. 16:13
ref.
949
기사링크 :
https://www.hankyung.com/article/2024011668791
Prev:
뉴스(뉴시스) - 박셀바이오, JBRC·써모피셔와 3자 융합 업무협약 체결
Next:
뉴스(이데일리) - 박셀바이오, CAR-MILs 개발 순항…다발골수종 치료제 특허 출원
List
